Nurix CSO Gwenn Hansen disposes of 1,452 common shares worth $36,982.44
NRIX•Nurix CSO share transaction
- Nurix Therapeutics Chief Scientific Officer Gwenn Hansen exercised employee stock options for 1,452 shares at USD 1.86 on Sept. 1, 2026.
- Hansen sold 1,452 shares at USD 25.47 the same day.
- Directly held common stock ended at 117,227 shares.
